Get High-quality Peripheral Blood Mononuclear Cells From Covid 19 Patients

By Author: Central BioHub
Total Articles: 113
Comment this article

COVID-19 Biospecimens for Advanced Research
COVID-19 is an acute severe respiratory infection caused by a mutated strain of coronavirus called SARS-CoV-2. Since 2019, COVID-19 has caused countless fatalities across the globe. Due to the severity of the illness, the World Health Organization (WHO) formally declared COVID-19 a public health emergency of worldwide concern on January 30, 2020. At the same time, researchers worldwide are analyzing COVID-19 biospecimens obtained from individuals with suspected or clinically confirmed cases to find definitive therapies and more accurate diagnostic tools for better management of the global pandemic. Let us understand more about COVID-19 biospecimens.

COVID-19 biospecimens refer to a diverse range of human samples taken from people who have been found infected with the SARS-CoV-2 virus. The widely used human biospecimens include serum, plasma, whole blood, oropharyngeal secretions, and nasopharyngeal secretions that have been screened for SARS-CoV-2 antibodies or antigens collected, processed, and stored in state-of-the-art biobanks.

Role of Peripheral Blood Mononuclear ...
... Cells in COVID-19 Research
The unclear disease pathway and abnormal immune response are the main roadblocks for researchers to discover a permanent cure for many diseases. Nowadays, researchers are increasingly relying on peripheral blood mononuclear cells (PBMCs) to conduct leading molecular and immunological studies on the short-term and long-term effects of a COVID-19 infection. To create a successful treatment, it is imperative to comprehend the mechanism that causes immunological dysfunction in severe coronavirus disease 2019 (COVID-19). As we know, peripheral blood mononuclear cells (PBMCs) play a crucial role in human immunity studies on PBMCs collected from COVID-19 patients, and samples of infected and convalescent people can unlock barely known information about the COVID-19 infection.

Best quality Human PBMC Samples for COVID-19 Research
Thinking forward to the biospecimen revolution, Central BioHub connects certified global biospecimen suppliers to life science researchers worldwide. With the efforts to streamline the tedious biospecimen procurement process, our most extensive clinical network caters to biosample demands from the researchers enabling them to procure clinical research samples through our online marketplace.

To lead advanced COVID-19 research, Central BioHub offers ethically sourced, well-annotated human peripheral blood mononuclear cells (PBMCs) obtained from patients with acute or convalescent SARS-CoV-2 infection. Check out our latest inventory update and order samples online: https://centralbiohub.de/blogs/human-pbmc-samples-for-research
All PBMC biospecimens are well-annotated with relevant clinical information and critically screened for respective laboratory parameters, and well preserved cryogenically at

Our company was founded by a group of scientists, who were confronted with the time-consuming process of human biospecimen procurement. Our experiences have motivated us to develop an online marketplace, that connects people in the life science sector who need human biological samples and the suppliers who offer them.